TOKYO--(BUSINESS WIRE)--'BioJapan 2013 -World Business Forum' will be held from October 9th to 11th, 2013 at Pacifico Yokohama in Exhibition Halls C & D, and the Annex Hall.
BioJapan is an event comprised of exhibitions, seminars, and business partnering meetings geared for the Japanese and global biotechnology industry’s top executives. The theme of this 15th assembly is ‘Towards A New Biotechnology Revolution’. Representatives from biotech industries from various countries will gather here to share technology and information, as well as share ideas for further development.
More than 700 companies from over 25 countries and regions are expected to participate this year! (a 30% increase from last year)
Participants from a wide range of countries and regions have already been confirmed, some of whom will exhibit in large pavilions. Domestic participants include the official sponsors of the event, Chugai Pharmaceutical, Kyowa Hakko Kirin, MSD, and Novartis Pharma, as well as a large number of global pharmaceutical companies, small to medium-sized pharmaceutical companies, bio-ventures, biotech affiliated companies, and domestic research institutions and universities.
An Updated business matching system!
The business matching system has undergone overwhelming improvements, making the process of arranging 'One to One Meetings' more efficient and more effective! This year's business meeting target is 5,000 pairings; a 50% increase over last year’s event.
Check the URL below for a list of companies participating in partnering. At the time of writing (Aug. 20th), 444 companies have already registered!
There will also be over 150 sponsor seminars and presentations from exhibitors!
Keynote speeches that will kick off the event will feature Yuko Harayama (Member of the Council for Science and Technology Policy, Cabinet Office, Government of Japan), Lim Chuan Poh (Director at the Agency for Science, Technology Research -Singapore), and Shigetaka Komori (Chairman and CEO, Representative Director of FUJIFILM Holdings Corporation). In addition, seminars from the organizers and exhibitors will address key themes in medical and pharmaceutical technology including regenerative medicine, which is now on the verge of clinical trials, as well as a vast range of topics concerning the environment, energy, healthcare, food and agricultural business, and biotech's industrial base.